Dr. Elaine Leung achieved her B.Sc. (Hons) degree in Molecular Biotechnology in 2001 at the Chinese University of Hong Kong (CUHK). She earned her M.Phil. degree in Biochemistry and Ph.D. degree in Physiology from CUHK at 2003 and 2006. She proceeded to her post-doctorial training at Department of Pathology at the Li Ka Shing Faculty of Medicine from the University of Hong Kong (HKU) during 2006-2011. She has received oversea research training awards in her Ph.D. and Post-doctoral training period for conducting research in Canada and the United State. During her time in HKU, she has published several well-recognized peer-reviewed research articles about lung cancer in the fields of molecular targeted therapy, combinational therapy and cancer genomic. Before joining Macau University of Science and Technology (MUST), Dr. Leung has been working as Post-doctorial research fellow at the School of Chinese Medicine at the Hong Kong Baptist University. She starts trying to identify novel drug candidates from natural products. Now in MUST, her research focuses on the application of proteomic technological platform for novel biomarkers and pharmaceutical targets discovery as well as understanding the molecular mechanisms of Traditional Chinese Medicine (TCM) for treatment of inflammatory disease and cancer. Another scope of her research interests is about the potential combination therapy and multi-target action of TCM for treatment of inflammatory disease and cancer. In July 2013, she was appointed as Assistant Director of Macau Institute for Applied Research in Medicine and Health. Teaching and Research Areas: Teaching subjects: Biochemistry, Modern Biotechnology, Methodology in Pharmacology of Chinese Medicines, Current Topics in Research of Chinese Medicine, Clinical Pharmacology, Professional English Research Areas: Chinese herbal pharmacology and molecular pharmacology, omics technology for innovative drug research, molecular targeting and treatment mechanisms of natural products on lung cancer, drug resistance mechanism in lung cancer, potential combinational use and synergies of natural products